戻る Agenda
Session 1: RECENT DEVELOPMENTS OF ICH
Session Chair(s)
Sarah Adam
Associate Director, Regulatory Affairs
IFPMA, Switzerland
Speaker(s)
Revised ICH Procedures to clarify Roles of Regulators / Industry
Sarah Adam
IFPMA, Switzerland
Associate Director, Regulatory Affairs
Increased Transparency of ICH Activities
Cornelia Meyer
ICH Secretariat, Switzerland
ICH Coordinator
MedDRA Governance and Development
Claudia M. Lehmann
Boehringer Ingelheim Pharma GmbH & Co KG, Germany
Head Global Pharmacovigilance Operations